Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 31, 2020

SELL
$46.96 - $61.67 $1.89 Million - $2.48 Million
-40,200 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$59.47 - $93.1 $4.05 Million - $6.34 Million
-68,141 Reduced 62.89%
40,200 $3.69 Million
Q2 2019

Jul 30, 2019

SELL
$75.84 - $105.21 $3.58 Million - $4.96 Million
-47,167 Reduced 30.33%
108,341 $13.8 Million
Q1 2019

May 13, 2019

SELL
$64.44 - $104.11 $2.67 Million - $4.31 Million
-41,430 Reduced 21.04%
155,508 $24.5 Million
Q4 2018

Feb 01, 2019

SELL
$59.1 - $93.26 $12 Million - $19 Million
-203,706 Reduced 50.84%
196,938 $19.5 Million
Q3 2018

Nov 07, 2018

BUY
$88.86 - $117.49 $12.2 Million - $16.1 Million
137,323 Added 52.15%
400,644 $58.5 Million
Q2 2018

Aug 07, 2018

BUY
$99.64 - $127.59 $6.57 Million - $8.41 Million
65,922 Added 33.4%
263,321 $41.3 Million
Q1 2018

May 14, 2018

BUY
$105.8 - $150.94 $8.03 Million - $11.5 Million
75,937 Added 62.52%
197,399 $33.7 Million
Q4 2017

Feb 12, 2018

SELL
$81.25 - $130.7 $1.06 Million - $1.71 Million
-13,069 Reduced 9.71%
121,462 $21.6 Million
Q3 2017

Nov 09, 2017

BUY
$57.74 - $91.42 $857,323 - $1.36 Million
14,848 Added 12.41%
134,531 $18.5 Million
Q2 2017

Aug 11, 2017

BUY
N/A
37,021 Added 44.79%
119,683 $12.6 Million
Q1 2017

May 15, 2017

BUY
N/A
7,017 Added 9.28%
82,662 $7.51 Million
Q4 2016

Feb 13, 2017

BUY
N/A
75,645
75,645 $4.67 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $29.3M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.